Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diamond V is a leading global provider of fermentation-based technologies designed to improve animal health, animal performance, and food safety. Founded in 1943 and headquartered in Cedar Rapids, Iowa, the company specializes in the development of postbiotic products derived from proprietary microbial fermentation processes. These products contain unique metabolites that support the immune system and digestive health across various species, including livestock, poultry, aquaculture, and companion animals. In 2018, Diamond V was acquired by Cargill, integrating its research-driven nutritional health solutions into Cargill's global animal nutrition business. The company continues to operate as a premier brand within the Cargill portfolio, focusing on sustainable and natural alternatives to traditional animal health interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diamond V.